Children's Health Defense The Maine Board of Licensure in Medicine on Tuesday called two witnesses to testify in its third hearing on the suspension of Dr. Meryl Nass over her treatment of patients with COVID-19. Under cross-examination, the first witness was forced to walk back many of his claims.
The Maine Board of Licensure in Medicine on Tuesday held its third hearing on the suspension of Dr. Meryl Nass related to her treatment recommendations for patients with COVID-19.
As it did on day two of the hearings, held on Oct. 27, 2022, the board focused on Nass’ alleged “sloppy” record-keeping for three patients she treated and on her prescribing of ivermectin and hydroxychloroquine for those patients.
The board suspended Nass, a member of the Children’s Health Defense scientific advisory board, on Jan. 12, 2022, without a hearing.
